Administration: The injection typically takes only a few minutes
So, how do we solve this problem
The clinical trial protocol starts at 0.25 mg to 0.3 mg weekly and increases every 4 weeks through escalation steps of 0.6 mg, 1.2 mg, 1.8 mg, and finally 2.4 mg
It can withstand the acidic environment of the stomach without breaking down, which explains why oral formulations exist alongside injectable versions
The combination accelerates wound closure, reduces inflammation, minimizes scar formation, and promotes proper tissue organization
The gastrointestinal research on BPC-157, while not directly relevant to hip injuries, reveals something important about the peptides safety profile